Windtree Therapeutics Inc expected to post a loss of $2.27 a share - Earnings Preview

Windtree Therapeutics

06/11/2024 13:55

* Windtree Therapeutics Inc  WINT.OQ   WINT.O  is expected
to show
no change in quarterly revenue when it reports  results on
November 8 (estimated) for the period ending September 30 2024
    * 
    * ​LSEG's mean analyst estimate for Windtree Therapeutics
Inc is
for a loss of $2.27 per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Windtree
Therapeutics Inc is $7.00​, above​ its last closing price
of $0.69. ​​​

This summary was machine generated November 6 at 13:55 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)